Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Zhaohui Pharmaceutical, a subsidiary of Fosun Pharma, is a prominent Chinese pharmaceutical company specializing in the development and production of chemical drugs. Established in 1958, the company has evolved into a comprehensive enterprise with advanced manufacturing capabilities for oral solids, topicals, and injections. Zhaohui is particularly well-regarded for its dermatology portfolio, including widely recognized brands for treating skin conditions like dermatitis and fungal infections. Beyond dermatology, the company maintains a significant presence in the cardiovascular and metabolic therapeutic areas. As part of the Fosun Pharma group, Zhaohui adheres to rigorous international quality standards and exports its products to various global markets. The company continues to focus on providing high-quality, affordable generic medications while expanding its manufacturing excellence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhaohui Pharmaceutical.